Skip to main content


Placeholder slot

This page contains brief information about pembrolizumab (Keytruda) and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Pembrolizumab is approved to treat:

¹This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that pembrolizumab provides a clinical benefit in these patients.

Pembrolizumab is also being studied in the treatment of other types of cancer.

More About Pembrolizumab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Pembrolizumab - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Study Details Long-Term Side Effects of Immune Checkpoint Inhibitors

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

A New FDA Approval Furthers the Role of Genomics in Cancer Care

Monoclonal Antibodies

Immune Checkpoint Inhibitors

Pembrolizumab Approved for Some Patients with Advanced Esophageal Cancer

New Drugs, New Side Effects: Complications of Cancer Immunotherapy

Clinical Trials Accepting Patients

Find Clinical Trials for Pembrolizumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: